Kidney Drug Developers Should Have Warned Investors of FDA Issues, Shareholder Says

Delaware Business Court Insider

Feb 17, 2021

A complaint filed against Tricida Inc. and its directors Monday in the District of Delaware says the company touting its drug candidate as likely to be approved in August, then giv…